Factor VIII inhibitors development following introduction of B-domain-deleted recombinant factor VIII in four hemophilia A previously treated patients

J Thromb Haemost. 2003 Nov;1(11):2450-1. doi: 10.1046/j.1538-7836.2003.0468a.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibody Formation
  • Factor VIII / immunology*
  • Factor VIII / therapeutic use
  • Hemophilia A / drug therapy*
  • Hemophilia A / immunology
  • Humans
  • Isoantibodies / blood
  • Middle Aged
  • Peptide Fragments / immunology
  • Peptide Fragments / therapeutic use

Substances

  • B-domain-deleted factor VIII
  • Isoantibodies
  • Peptide Fragments
  • Factor VIII